← Back to Search

Other

Light + Online Therapy for ADHD

N/A
Recruiting
Led By Emily J Ricketts, Ph.D.
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 weeks
Awards & highlights

Summary

This trial will test if a combination of light therapy and online therapy can help teens with ADHD and poor sleep schedules.

Who is the study for?
This trial is for adolescents aged 14-17 with ADHD-combined type and delayed sleep-wake schedules. They must have trouble sleeping early, difficulty waking up, significant ADHD severity, an evening chronotype, and moderate to severe global functioning impairment. Participants need to be attending school during the study and fluent in English.
What is being tested?
The study tests flashed light therapy alone for two weeks followed by a combination of daily light therapy with weekly videoconference-delivered cognitive behavioral therapy sessions targeting circadian rhythms and sleep over four weeks.
What are the potential side effects?
Potential side effects are not explicitly listed but may include discomfort or changes in sleep patterns due to the light therapy. Cognitive behavioral therapy typically does not have physical side effects but can sometimes cause temporary increases in distress.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Treatment Feasibility: Child-reported
Treatment Feasibility: Parent-reported
Treatment Tolerability: Attrition
+1 more
Secondary study objectives
Assessment Tolerability: Child-reported
Assessment Tolerability: Parent-reported
Treatment Sensitivity of Circadian Phase
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: 1) Flashed Light Therapy, 2) Flashed Light Therapy with Cognitive Behavioral TherapyExperimental Treatment2 Interventions
Treatment Phase 1 (2 weeks duration): light flashes administered for 60 minutes daily beginning 75 minutes prior to the participant's average morning wake time and ending 15 minutes before average morning wake time. Treatment Phase 2 (4 weeks duration): will begin immediately following phase 1 and involve daily light flashes (as described above) combined with weekly 50-minute videoconference-delivered cognitive-behavioral therapy.

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,554 Previous Clinical Trials
10,264,110 Total Patients Enrolled
11 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
1,116 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Emily J Ricketts, Ph.D.Principal InvestigatorUniversity of California, Los Angeles
~2 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top